Moti L Kashyap

Title(s)Emeritus Faculty, Medicine
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(562) 826-5844, 5748
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Niacin increases human aortic endothelial Sirt1 activity and nitric oxide: effect on endothelial function and vascular aging. Am J Transl Res. 2023; 15(12):6771-6778. Ganji S, Kamanna S, Kamanna VS, Kashyap ML. PMID: 38186996; PMCID: PMC10767546.
      View in: PubMed   Mentions: 3  
    2. Niacin regresses collagen content in human hepatic stellate cells from liver transplant donors with fibrotic non-alcoholic steatohepatitis (NASH). Am J Transl Res. 2022; 14(6):4006-4014. Ganji S, Hoa N, Kamanna J, Kamanna VS, Kashyap ML. PMID: 35836902; PMCID: PMC9274597.
      View in: PubMed   Mentions:
    3. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease. Am Heart J. 2020 06; 224:65-76. Boden WE, Miller MG, McBride R, Harvey C, Snabes MC, Schmidt J, McGovern ME, Fleg JL, Desvigne-Nickens P, Anderson T, Kashyap M, Probstfield JL. PMID: 32335402.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    4. Niacin for treatment of nonalcoholic fatty liver disease (NAFLD): novel use for an old drug? J Clin Lipidol. 2019 Nov - Dec; 13(6):873-879. Kashyap ML, Ganji S, Nakra NK, Kamanna VS. PMID: 31706905.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    5. Association of Serum Paraoxonase/Arylesterase Activity With All-Cause Mortality in Maintenance Hemodialysis Patients. J Clin Endocrinol Metab. 2019 10 01; 104(10):4848-4856. Suematsu Y, Goto M, Park C, Nunes ACF, Jing W, Streja E, Rhee CM, Cruz S, Kashyap ML, Vaziri ND, Narayanaswami V, Kalantar-Zadeh K, Moradi H. PMID: 30920627; PMCID: PMC6733492.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    6. Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease. J Endocr Soc. 2019 Oct 01; 3(10):1869-1880. Moradi H, Park C, Igarashi M, Streja E, Argueta DA, Soohoo M, Daglian J, You AS, Rhee CM, Kashyap ML, DiPatrizio NV, Vaziri ND, Kalantar-Zadeh K, Piomelli D. PMID: 31583368; PMCID: PMC6767629.
      View in: PubMed   Mentions: 9  
    7. Effects of Extended-Release Niacin on Quartile Lp-PLA2 Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial. J Cardiovasc Pharmacol Ther. 2019 11; 24(6):534-541. Lyubarova R, Albers JJ, Marcovina SM, Yao Y, McBride R, Topliceanu A, Anderson T, Fleg JL, Desvigne-Nickens P, Kashyap ML, McGovern ME, Boden WE. PMID: 31131629.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Statin Therapy Before Transition to End-Stage Renal Disease With Posttransition Outcomes. J Am Heart Assoc. 2019 03 19; 8(6):e011869. Soohoo M, Moradi H, Obi Y, Rhee CM, Gosmanova EO, Molnar MZ, Kashyap ML, Gillen DL, Kovesdy CP, Kalantar-Zadeh K, Streja E. PMID: 30885048; PMCID: PMC6475049.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    9. Cardiovascular outcomes during extended follow-up of the AIM-HIGH trial cohort. J Clin Lipidol. 2018 Nov - Dec; 12(6):1413-1419. Probstfield JL, Boden WE, Anderson T, Branch K, Kashyap M, Fleg JL, Desvigne-Nickens P, McBride R, McGovern M, AIM-HIGH Investigators. PMID: 30131256.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Inverse Association Between Serum Non-High-Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis. J Am Heart Assoc. 2018 06 09; 7(12). Chang TI, Streja E, Ko GJ, Naderi N, Rhee CM, Kovesdy CP, Kashyap ML, Vaziri ND, Kalantar-Zadeh K, Moradi H. PMID: 29886420; PMCID: PMC6220529.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    11. Increments in serum high-density lipoprotein cholesterol over time are not associated with improved outcomes in incident hemodialysis patients. J Clin Lipidol. 2018 Mar - Apr; 12(2):488-497. Chang TI, Streja E, Soohoo M, Ko GJ, Rhee CM, Kovesdy CP, Kashyap ML, Vaziri ND, Kalantar-Zadeh K, Moradi H. PMID: 29456130.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    12. LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis, and Vasculopathy in a Rat Model of Chronic Kidney Disease. J Card Fail. 2018 Apr; 24(4):266-275. Suematsu Y, Jing W, Nunes A, Kashyap ML, Khazaeli M, Vaziri ND, Moradi H. PMID: 29325796.
      View in: PubMed   Mentions: 44     Fields:    Translation:Animals
    13. Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients. Clin J Am Soc Nephrol. 2017 Apr 03; 12(4):591-602. Chang TI, Streja E, Soohoo M, Kim TW, Rhee CM, Kovesdy CP, Kashyap ML, Vaziri ND, Kalantar-Zadeh K, Moradi H. PMID: 28193609; PMCID: PMC5383388.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    14. Reverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population. J Am Med Dir Assoc. 2015 Nov 01; 16(11):933-9. Ahmadi SF, Streja E, Zahmatkesh G, Streja D, Kashyap M, Moradi H, Molnar MZ, Reddy U, Amin AN, Kovesdy CP, Kalantar-Zadeh K. PMID: 26363864; PMCID: PMC4636955.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    15. Association of serum lipids with outcomes in Hispanic hemodialysis patients of the West versus East Coasts of the United States. Am J Nephrol. 2015; 41(4-5):284-95. Moradi H, Abhari P, Streja E, Kashyap ML, Shah G, Gillen D, Pahl MV, Vaziri ND, Kalantar-Zadeh K. PMID: 26044456; PMCID: PMC5680076.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    16. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease. Metabolism. 2015 Sep; 64(9):982-90. Ganji SH, Kashyap ML, Kamanna VS. PMID: 26024755.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    17. Niacin and progression of CKD. Am J Kidney Dis. 2015 May; 65(5):785-98. Streja E, Kovesdy CP, Streja DA, Moradi H, Kalantar-Zadeh K, Kashyap ML. PMID: 25708553.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    18. Safety profile of extended-release niacin in the AIM-HIGH trial. N Engl J Med. 2014 Jul 17; 371(3):288-90. Anderson TJ, Boden WE, Desvigne-Nickens P, Fleg JL, Kashyap ML, McBride R, Probstfield JL, AIM-HIGH Investigators. PMID: 25014706; PMCID: PMC4156937.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    19. Niacin decreases leukocyte myeloperoxidase: mechanistic role of redox agents and Src/p38MAP kinase. Atherosclerosis. 2014 Aug; 235(2):554-61. Ganji SH, Kamanna VS, Kashyap ML. PMID: 24956528.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    20. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. Nephrol Dial Transplant. 2014 Aug; 29(8):1554-62. Moradi H, Streja E, Kashyap ML, Vaziri ND, Fonarow GC, Kalantar-Zadeh K. PMID: 24574544; PMCID: PMC4106641.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    21. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2014 Feb 15; 306(4):G320-7. Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS. PMID: 24356885.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    22. Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes). J Am Coll Cardiol. 2013 Oct 22; 62(17):1575-9. Albers JJ, Slee A, O'Brien KD, Robinson JG, Kashyap ML, Kwiterovich PO, Xu P, Marcovina SM. PMID: 23973688; PMCID: PMC3800510.
      View in: PubMed   Mentions: 114     Fields:    Translation:Humans
    23. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). J Am Coll Cardiol. 2013 Oct 22; 62(17):1580-4. Guyton JR, Slee AE, Anderson T, Fleg JL, Goldberg RB, Kashyap ML, Marcovina SM, Nash SD, O'Brien KD, Weintraub WS, Xu P, Zhao XQ, Boden WE. PMID: 23916935; PMCID: PMC3862446.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    24. Mammalian colonocytes possess a carrier-mediated mechanism for uptake of vitamin B3 (niacin): studies utilizing human and mouse colonic preparations. Am J Physiol Gastrointest Liver Physiol. 2013 Aug 01; 305(3):G207-13. Kumar JS, Subramanian VS, Kapadia R, Kashyap ML, Said HM. PMID: 23744738; PMCID: PMC3742858.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    25. Recent advances in niacin and lipid metabolism. Curr Opin Lipidol. 2013 Jun; 24(3):239-45. Kamanna VS, Ganji SH, Kashyap ML. PMID: 23619367.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    26. Role of HDL dysfunction in end-stage renal disease: a double-edged sword. J Ren Nutr. 2013 May; 23(3):203-6. Moradi H, Vaziri ND, Kashyap ML, Said HM, Kalantar-Zadeh K. PMID: 23611547; PMCID: PMC3664234.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    27. Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells. J Lipid Res. 2012 May; 53(5):941-950. Zhang LH, Kamanna VS, Ganji SH, Xiong XM, Kashyap ML. PMID: 22389325; PMCID: PMC3329393.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    28. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice. J Cardiovasc Pharmacol Ther. 2012 Sep; 17(3):334-43. Qin S, Kamanna VS, Lai JH, Liu T, Ganji SH, Zhang L, Bachovchin WW, Kashyap ML. PMID: 22308547.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    29. Niacin extended-release therapy in phase III clinical trials is associated with relatively low rates of drug discontinuation due to flushing and treatment-related adverse events: a pooled analysis. Am J Cardiovasc Drugs. 2011 Jun 01; 11(3):179-87. Brinton EA, Kashyap ML, Vo AN, Thakkar RB, Jiang P, Padley RJ. PMID: 21619381.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    30. Pioglitazone increases apolipoprotein A-I production by directly enhancing PPRE-dependent transcription in HepG2 cells. J Lipid Res. 2010 Aug; 51(8):2211-22. Zhang LH, Kamanna VS, Ganji SH, Xiong XM, Kashyap ML. PMID: 20371549; PMCID: PMC2903821.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    31. The mechanism and mitigation of niacin-induced flushing. Int J Clin Pract. 2009 Sep; 63(9):1369-77. Kamanna VS, Ganji SH, Kashyap ML. PMID: 19691622; PMCID: PMC2779993.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    32. Acetylsalicylic acid reduces niacin extended-release-induced flushing in patients with dyslipidemia. Am J Cardiovasc Drugs. 2009; 9(2):69-79. Thakkar RB, Kashyap ML, Lewin AJ, Krause SL, Jiang P, Padley RJ. PMID: 19331435.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    33. Niacin: an old drug rejuvenated. Curr Atheroscler Rep. 2009 Jan; 11(1):45-51. Kamanna VS, Ganji SH, Kashyap ML. PMID: 19080727.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    34. Fixed-dose combination of extended-release niacin plus simvastatin for lipid disorders. Expert Rev Cardiovasc Ther. 2008 Nov; 6(10):1303-10. Vo AN, Kashyap ML. PMID: 19018682.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    35. Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study. Atherosclerosis. 2009 May; 204(1):208-15. Jones PH, Davidson MH, Kashyap ML, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC. PMID: 18996523.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    36. Nicotinic acid: recent developments. Curr Opin Cardiol. 2008 Jul; 23(4):393-8. Kamanna VS, Vo A, Kashyap ML. PMID: 18520725.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    37. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells. Metabolism. 2008 Jul; 57(7):973-9. Qin S, Koga T, Ganji SH, Kamanna VS, Kashyap ML. PMID: 18555840.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    38. Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells. Atherosclerosis. 2009 Jan; 202(1):68-75. Ganji SH, Qin S, Zhang L, Kamanna VS, Kashyap ML. PMID: 18550065.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCells
    39. Mechanism of action of niacin. Am J Cardiol. 2008 Apr 17; 101(8A):20B-26B. Kamanna VS, Kashyap ML. PMID: 18375237.
      View in: PubMed   Mentions: 126     Fields:    Translation:Humans
    40. Niacin inhibits surface expression of ATP synthase beta chain in HepG2 cells: implications for raising HDL. J Lipid Res. 2008 Jun; 49(6):1195-201. Zhang LH, Kamanna VS, Zhang MC, Kashyap ML. PMID: 18316796.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    41. Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study. Am J Cardiovasc Drugs. 2008; 8(2):69-81. Karas RH, Kashyap ML, Knopp RH, Keller LH, Bajorunas DR, Davidson MH. PMID: 18422390.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    42. Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents? Am J Cardiol. 2007 Dec 03; 100(11 A):S53-61. Kamanna VS, Kashyap ML. PMID: 18047854.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    43. Mechanism of nicotinic acid transport in human liver cells: experiments with HepG2 cells and primary hepatocytes. Am J Physiol Cell Physiol. 2007 Dec; 293(6):C1773-8. Said HM, Nabokina SM, Balamurugan K, Mohammed ZM, Urbina C, Kashyap ML. PMID: 17928533.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    44. Pioglitazone stimulates apolipoprotein A-I production without affecting HDL removal in HepG2 cells: involvement of PPAR-alpha. Arterioscler Thromb Vasc Biol. 2007 Nov; 27(11):2428-34. Qin S, Liu T, Kamanna VS, Kashyap ML. PMID: 17872455.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    45. Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study). Atherosclerosis. 2007 Jun; 192(2):432-7. McKenney JM, Jones PH, Bays HE, Knopp RH, Kashyap ML, Ruoff GE, McGovern ME. PMID: 17239888.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    46. Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush. Atherosclerosis. 2007 Jun; 192(2):253-8. Meyers CD, Liu P, Kamanna VS, Kashyap ML. PMID: 16945375.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    47. Baseline achievement of lipid goals and usage of lipid medications in patients with diabetes mellitus (from the Veterans Affairs Diabetes Trial). Am J Cardiol. 2006 Jul 01; 98(1):63-5. Meyers CD, McCarren M, Wong ND, Abraira C, Duckworth WC, Kashyap ML, VADT Investigators. PMID: 16784922.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    48. Anticipating the evolution of clinical cholesterol guidelines: implications of recent statin intervention trials. Future Cardiol. 2005 Jul; 1(4):461-71. Meyers CD, Wong N, Kashyap ML. PMID: 19804146.
      View in: PubMed   Mentions:    Fields:    
    49. Pharmacologic augmentation of high-density lipoproteins: mechanisms of currently available and emerging therapies. Curr Opin Cardiol. 2005 Jul; 20(4):307-12. Meyers CD, Kashyap ML. PMID: 15956828.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    50. Mechanism and regulation of human intestinal niacin uptake. Am J Physiol Cell Physiol. 2005 Jul; 289(1):C97-103. Nabokina SM, Kashyap ML, Said HM. PMID: 15728713.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    51. Niacin therapy in atherosclerosis. Curr Opin Lipidol. 2004 Dec; 15(6):659-65. Meyers CD, Kamanna VS, Kashyap ML. PMID: 15529025.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    52. Pharmacologic treatment of type 2 diabetic dyslipidemia. Pharmacotherapy. 2004 Dec; 24(12):1692-713. Moon YS, Kashyap ML. PMID: 15585439.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    53. Management of the metabolic syndrome-nicotinic acid. Endocrinol Metab Clin North Am. 2004 Sep; 33(3):557-75, vii. Meyers CD, Kashyap ML. PMID: 15262297.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    54. Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells. J Lipid Res. 2004 Oct; 45(10):1835-45. Ganji SH, Tavintharan S, Zhu D, Xing Y, Kamanna VS, Kashyap ML. PMID: 15258194.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    55. Pharmacologic elevation of high-density lipoproteins: recent insights on mechanism of action and atherosclerosis protection. Curr Opin Cardiol. 2004 Jul; 19(4):366-73. Meyers CD, Kashyap ML. PMID: 15218398.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    56. Niacin, lipids, and heart disease. Curr Cardiol Rep. 2003 Nov; 5(6):470-6. Malik S, Kashyap ML. PMID: 14558989.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    57. Niacin and cholesterol: role in cardiovascular disease (review). J Nutr Biochem. 2003 Jun; 14(6):298-305. Ganji SH, Kamanna VS, Kashyap ML. PMID: 12873710.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    58. Dyslipidemia treatment: current considerations and unmet needs. Expert Rev Cardiovasc Ther. 2003 May; 1(1):121-34. Malik S, Kashyap ML. PMID: 15030302.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    59. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]). Am J Cardiol. 2003 Mar 15; 91(6):667-72. Bays HE, Dujovne CA, McGovern ME, White TE, Kashyap ML, Hutcheson AG, Crouse JR, ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation. PMID: 12633795.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    60. Optimal therapy of low levels of high density lipoprotein-cholesterol. Am J Cardiovasc Drugs. 2003; 3(1):53-65. Kashyap ML, Tavintharan S, Kamanna VS. PMID: 14727946.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    61. Niacin extended-release/lovastatin: combination therapy for lipid disorders. Expert Opin Pharmacother. 2002 Dec; 3(12):1763-71. Moon YS, Kashyap ML. PMID: 12472373.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    62. Effect of gemfibrozil on apolipoprotein B secretion and diacylglycerol acyltransferase activity in human hepatoblastoma (HepG2) cells. Atherosclerosis. 2002 Oct; 164(2):221-8. Zhu D, Ganji SH, Kamanna VS, Kashyap ML. PMID: 12204791.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    63. Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia. Am J Cardiol. 2002 Mar 15; 89(6):672-8. Kashyap ML, McGovern ME, Berra K, Guyton JR, Kwiterovich PO, Harper WL, Toth PD, Favrot LK, Kerzner B, Nash SD, Bays HE, Simmons PD. PMID: 11897208.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCTClinical Trials
    64. Clinical aspects of dyslipidemia. Manag Care. 2001 Nov; 10(11 Suppl):4-9; discussion 19-24. Kashyap M. PMID: 11761628.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    65. Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol. Arterioscler Thromb Vasc Biol. 2001 Nov; 21(11):1783-9. Sakai T, Kamanna VS, Kashyap ML. PMID: 11701466.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    66. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA. 2001 Mar 28; 285(12):1585-91. Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB, VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial. PMID: 11268266.
      View in: PubMed   Mentions: 198     Fields:    Translation:HumansCTClinical Trials
    67. The benefits of niacin in atherosclerosis. Curr Atheroscler Rep. 2001 Jan; 3(1):74-82. Tavintharan S, Kashyap ML. PMID: 11123852.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    68. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. Arch Intern Med. 2000 Apr 24; 160(8):1177-84. Guyton JR, Blazing MA, Hagar J, Kashyap ML, Knopp RH, McKenney JM, Nash DT, Nash SD. PMID: 10789612.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    69. Albumin inhibits apolipoprotein AI and AII production in human hepatoblastoma cell line (Hep G2): additive effects of oleate-albumin complex. Atherosclerosis. 2000 Mar; 149(1):43-9. Sakai T, Jin FY, Kamanna VS, Kashyap ML. PMID: 10704613.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    70. Dietitian intervention improves lipid values and saves medication costs in men with combined hyperlipidemia and a history of niacin noncompliance. J Am Diet Assoc. 2000 Feb; 100(2):218-24. Sikand G, Kashyap ML, Wong ND, Hsu JC. PMID: 10670395.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    71. Mechanism of action of niacin on lipoprotein metabolism. Curr Atheroscler Rep. 2000 Jan; 2(1):36-46. Kamanna VS, Kashyap ML. PMID: 11122723.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    72. Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells. Arterioscler Thromb Vasc Biol. 1999 Apr; 19(4):1051-9. Jin FY, Kamanna VS, Kashyap ML. PMID: 10195935.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    73. Mechanistic studies of high-density lipoproteins. Am J Cardiol. 1998 Dec 17; 82(12A):42U-48U; discussion 85U-86U. Kashyap ML. PMID: 9915662.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    74. Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia. Metabolism. 1998 Sep; 47(9):1097-104. Knopp RH, Alagona P, Davidson M, Goldberg AC, Kafonek SD, Kashyap M, Sprecher D, Superko HR, Jenkins S, Marcovina S. PMID: 9751239.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    75. Medical nutrition therapy lowers serum cholesterol and saves medication costs in men with hypercholesterolemia. J Am Diet Assoc. 1998 Aug; 98(8):889-94; quiz 895-6. Sikand G, Kashyap ML, Yang I. PMID: 9710659.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    76. Estradiol stimulates apolipoprotein A-I- but not A-II-containing particle synthesis and secretion by stimulating mRNA transcription rate in Hep G2 cells. Arterioscler Thromb Vasc Biol. 1998 Jun; 18(6):999-1006. Jin FY, Kamanna VS, Kashyap ML. PMID: 9633943.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    77. Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport. Arterioscler Thromb Vasc Biol. 1997 Oct; 17(10):2020-8. Jin FY, Kamanna VS, Kashyap ML. PMID: 9351367.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    78. Cholesterol and atherosclerosis: a contemporary perspective. Ann Acad Med Singap. 1997 Jul; 26(4):517-23. Kashyap ML. PMID: 9395824.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    79. Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans. Pharmacotherapy. 1997 May-Jun; 17(3):576-83. Konzem SL, Gray DR, Kashyap ML. PMID: 9165562.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    80. Effect of serum subfractions from peritoneal dialysis patients on Hep-G2 cell apolipoprotein A-I and B metabolism. Kidney Int. 1996 Dec; 50(6):2079-87. Shah GM, Lin ZL, Kamanna VS, Pai R, Bassa B, Jin FY, Roh DD, Kashyap ML, Kirschenbaum MA. PMID: 8943493.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    81. Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2). Arterioscler Thromb Vasc Biol. 1996 Aug; 16(8):1052-62. Jin FY, Kamanna VS, Chuang MY, Morgan K, Kashyap ML. PMID: 8696946.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    82. Fish oil as an adjuvant in the treatment of hypertension. Pharmacotherapy. 1996 Mar-Apr; 16(2):295-300. Gray DR, Gozzip CG, Eastham JH, Kashyap ML. PMID: 8820475.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    83. Immunochemical methods for quantification of human apolipoprotein C-III. Methods Enzymol. 1996; 263:208-18. Kashyap ML. PMID: 8749009.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    84. Noninvasive tracking of coronary atherosclerosis by electron beam computed tomography: rationale and design of the Felodipine Atherosclerosis Prevention Study (FAPS). Am J Cardiol. 1995 Dec 15; 76(17):1239-42. Wong ND, Teng W, Abrahamson D, Willner R, Henein N, Franklin SS, Kashyap ML, Rosenzweig B, Kukes G, Detrano RC. PMID: 7503003.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    85. Elevated plasma lipoprotein(a) levels and hypoalbuminemia in peritoneal dialysis patients. Int J Artif Organs. 1995 Dec; 18(12):751-6. Ross EA, Shah GM, Kashyap ML. PMID: 8964640.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    86. Characterization of a monoclonal antibody (HB-22) and development of an ELISA for human apolipoprotein A-I. Clin Chem. 1995 Aug; 41(8 Pt 1):1150-8. Rothwell TC, Kamanna VS, Jin FY, Koren E, Foley T, Kashyap ML. PMID: 7628090.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    87. Synovial fluid lipids and apolipoproteins: a contemporary perspective. Biorheology. 1995 Jan-Feb; 32(1):1-16. Prete PE, Gurakar-Osborne A, Kashyap ML. PMID: 7548857.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    88. Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans. Ann Intern Med. 1994 Aug 15; 121(4):252-8. Gray DR, Morgan T, Chretien SD, Kashyap ML. PMID: 7741833.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    89. Uremic serum subfraction inhibits apolipoprotein A-I production by a human hepatoma cell line. J Am Soc Nephrol. 1994 Aug; 5(2):193-200. Kamanna VS, Kashyap ML, Pai R, Bui DT, Jin FY, Roh DD, Shah GM, Kirschenbaum MA. PMID: 7993998.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    90. Alterations in reverse cholesterol transport associated with programmable implantable intraperitoneal insulin delivery. Metabolism. 1994 Jun; 43(6):665-9. Selam JL, Kashyap ML, Gupta AK, Turner D, Wong ND, Lozano JL, Charles MA. PMID: 8201953.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    91. High density lipoproteins stimulate the production and secretion of endothelin-1 from cultured bovine aortic endothelial cells. J Clin Invest. 1994 Mar; 93(3):1056-62. Hu RM, Chuang MY, Prins B, Kashyap ML, Frank HJ, Pedram A, Levin ER. PMID: 8132743; PMCID: PMC294036.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    92. Synovial fluid lipoproteins: review of current concepts and new directions. Semin Arthritis Rheum. 1993 Oct; 23(2):79-89. Prete PE, Gurakar-Osborne A, Kashyap ML. PMID: 8266111.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    93. Apolipoproteins A-I and B and cholesterol in synovial fluid of patients with rheumatoid arthritis. Metabolism. 1993 Jul; 42(7):803-6. Ananth L, Prete PE, Kashyap ML. PMID: 8345790.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    94. Increased reverse cholesterol transport in athletes. Metabolism. 1993 Jun; 42(6):684-90. Gupta AK, Ross EA, Myers JN, Kashyap ML. PMID: 8510511.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    95. Ethanol stimulates apolipoprotein A-I secretion by human hepatocytes: implications for a mechanism for atherosclerosis protection. Metabolism. 1992 Aug; 41(8):827-32. Amarasuriya RN, Gupta AK, Civen M, Horng YC, Maeda T, Kashyap ML. PMID: 1640859.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    96. HDL metabolism in HDL deficiency associated with familial hypertriglyceridemia: effect of treatment with gemfibrozil. Adv Exp Med Biol. 1991; 285:233-6. Kashyap ML, Saku K. PMID: 1907081.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    97. Relationship between post-heparin plasma lipases, triglycerides and high density lipoproteins in normal subjects. Horm Metab Res. 1990 May; 22(5):289-94. Jackson RL, Yates MT, McNerney CA, Kashyap ML. PMID: 2347543.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    98. Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus. Metabolism. 1989 Sep; 38(9):908-12. Selam JL, Kashyap M, Alberti KG, Lozano J, Hanna M, Turner D, Jeandidier N, Chan E, Charles MA. PMID: 2671601.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    99. Cardiovascular disease in the elderly: current considerations. Am J Cardiol. 1989 May 02; 63(16):3H-4H. Kashyap ML. PMID: 2705394.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    100. Basic considerations in the reversal of atherosclerosis: significance of high-density lipoprotein in stimulating reverse cholesterol transport. Am J Cardiol. 1989 May 02; 63(16):56H-59H. Kashyap ML. PMID: 2650526.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    101. Identification of an apoC-II variant (apoC-IIBethesda) in a kindred with apoC-II deficiency and type I hyperlipoproteinemia. J Lipid Res. 1988 Mar; 29(3):273-8. Sprecher DL, Taam L, Gregg RE, Fojo SS, Wilson DM, Kashyap ML, Brewer HB. PMID: 3379339.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    102. High-density lipoprotein apolipoprotein AI and AII turnover in moderate and severe proteinuria. Nephron. 1988; 50(2):112-5. Saku K, Mendoza SG, Laver M, Hynd BA, Gartside PS, Kashyap ML. PMID: 3146703.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    103. Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography. J Lipid Res. 1987 Aug; 28(8):913-29. Cheung MC, Segrest JP, Albers JJ, Cone JT, Brouillette CG, Chung BH, Kashyap M, Glasscock MA, Anantharamaiah GM. PMID: 3117954.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    104. Characterization of high density lipoproteins from patients with severe hypertriglyceridemia. Atherosclerosis. 1987 Jul; 66(1-2):37-43. Jackson RL, Barnhart RL, Kashyap ML. PMID: 3632752.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    105. Dietary fat in experimental nephrotic syndrome: beneficial effects of fish oil on serum lipids and, indirectly, on the kidney. Life Sci. 1987 Jun 15; 40(24):2317-24. Ito Y, Barcelli U, Yamashita W, Weiss M, Thompson B, Kashyap M, Deddens J, Pollak VE. PMID: 3586861.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    106. Human plasma lipid transfer protein catalyzes the speciation of high density lipoproteins. Biochim Biophys Acta. 1987 Apr 24; 918(3):260-6. Ellsworth JL, Kashyap ML, Jackson RL, Harmony JA. PMID: 3567214.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    107. Enzyme-linked immunoabsorbant assay of apolipoprotein AII in plasma, with use of a monoclonal antibody. Clin Chem. 1986 Jun; 32(6):967-71. Stein EA, DiPersio L, Pesce AJ, Kashyap M, Kao JT, Srivastava L, McNerney C. PMID: 3085983.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    108. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest. 1986 Feb; 77(2):520-7. Baggio G, Manzato E, Gabelli C, Fellin R, Martini S, Enzi GB, Verlato F, Baiocchi MR, Sprecher DL, Kashyap ML, et al. PMID: 3944267; PMCID: PMC423374.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    109. Sex hormones, lipids, lipoprotein cholesterols, and apolipoproteins in normal and obese subjects: atherogenic relationships. Int J Obes. 1986; 10(6):427-41. Mendoza SG, Zerpa A, Velazquez E, Schwarzenberg A, Hynd B, Kashyap ML, Laskarzewski P, Glueck CJ. PMID: 3100468.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    110. Comparison of gradient gel electrophoresis and zonal ultracentrifugation for quantitation of high density lipoproteins. J Lipid Res. 1985 Nov; 26(11):1363-7. McNerney CA, Kashyap ML, Barnhart RL, Jackson RL. PMID: 4067424.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    111. Familial apolipoprotein A-I and C-III deficiency, variant II. J Lipid Res. 1985 Sep; 26(9):1089-101. Schaefer EJ, Ordovas JM, Law SW, Ghiselli G, Kashyap ML, Srivastava LS, Heaton WH, Albers JJ, Connor WE, Lindgren FT, et al. PMID: 3934306.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    112. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia. Metabolism. 1985 Aug; 34(8):754-64. Saku K, Gartside PS, Hynd BA, Mendoza SG, Kashyap ML. PMID: 3927110.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    113. Mechanism of action of gemfibrozil on lipoprotein metabolism. J Clin Invest. 1985 May; 75(5):1702-12. Saku K, Gartside PS, Hynd BA, Kashyap ML. PMID: 3923042; PMCID: PMC425514.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    114. Effect of desialylation of very low-density lipoproteins on their catabolism by lipoprotein lipase. Metabolism. 1985 Jan; 34(1):30-5. Stoline AM, Saku K, Hynd BA, Kashyap ML. PMID: 3965860.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    115. C-II anapolipoproteinemia and severe hypertriglyceridemia. Report of a rare case with absence of C-II apolipoprotein isoforms and review of the literature. Am J Med. 1984 Sep; 77(3):457-62. Saku K, Cedres C, McDonald B, Hynd BA, Liu BW, Srivastava LS, Kashyap ML. PMID: 6475985.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    116. Effect of human high density lipoproteins, anti-apolipoproteins CII and CIII, and hydrolysis of very low density lipoprotein (VLDL) cholesterol ester on VLDL catabolism in vitro. Biochem Biophys Res Commun. 1984 Jun 29; 121(3):946-52. Liu BW, Hynd BA, Kashyap ML. PMID: 6588972.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    117. Renal handling of high-density lipoproteins by isolated perfused kidneys. Metabolism. 1984 May; 33(5):432-8. Saku K, Reddy GS, Hynd BA, Kashyap ML. PMID: 6717275.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    118. Influence of polyunsaturated and saturated fats on plasma lipids and lipoproteins in man. Am J Clin Nutr. 1984 Apr; 39(4):589-97. Jackson RL, Kashyap ML, Barnhart RL, Allen C, Hogg E, Glueck CJ. PMID: 6424427.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    119. Effect of a high carbohydrate diet on the content of apolipoproteins C-II, C-III and E in human plasma high density lipoprotein subfractions. Atherosclerosis. 1983 Mar; 46(3):341-52. Sasaki N, Holdsworth G, Barnhart RL, Srivastava LS, Glueck CJ, Kashyap ML, Jackson RL. PMID: 6847745.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    120. Alimentary lipemia: plasma high-density lipoproteins and apolipoproteins CII and CIII in healthy subjects. Am J Clin Nutr. 1983 Feb; 37(2):233-43. Kashyap ML, Barnhart RL, Srivastava LS, Perisutti G, Allen C, Hogg E, Glueck CJ, Jackson RL. PMID: 6823885.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    121. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion. Artery. 1983; 12(1):1-23. Mendoza SG, Zerpa A, Carrasco H, Colmenares O, Rangel A, Gartside PS, Kashyap ML. PMID: 6431945.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    122. Effects of dietary carbohydrate and fat on plasma lipoproteins and apolipoproteins C-II and C-III in healthy men. J Lipid Res. 1982 Aug; 23(6):877-86. Kashyap ML, Barnhart RL, Srivastava LS, Perisutti G, Vink P, Allen C, Hogg E, Brady D, Glueck CJ, Jackson RL. PMID: 7130856.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    123. In vitro catabolism of human plasma very low density lipoproteins. Effects of VLDL concentration on the interconversion of high density lipoprotein subfractions. Atherosclerosis. 1982 Feb; 41(2-3):381-94. Taskinen MR, Kashyap ML, Srivastava LS, Ashraf M, Johnson JD, Perisutti G, Brady D, Glueck CJ, Jackson RL. PMID: 7066084.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    124. Recent advances in the pathogenesis of lipoprotein disorders. Ann Acad Med Singap. 1981 Oct; 10(4 Suppl):73-6. Kashyap ML. PMID: 7344605.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    125. Effects of apolipoprotein C-II (apoC-II) on the lipolysis of very low density lipoproteins from apoC-II deficient patients. Metabolism. 1981 Aug; 30(8):818-24. Matsuoka N, Shirai K, Johnson JD, Kashyap ML, Srivastava LS, Yamamura T, Yamamoto A, Saito Y, Kumagai A, Jackson RL. PMID: 6894960.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    126. Hydrolysis of guinea pig nascent very low density lipoproteins catalyzed by lipoprotein lipase: activation by hjman apolipoprotein C-II. J Lipid Res. 1981 Aug; 22(6):921-33. Fitzharris TJ, Quinn DM, Goh EH, Johnson JD, Kashyap ML, Srivastava LS, Jackson RL, Harmony JA. PMID: 7276752.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    127. Quantitation of human apolipoprotein C-III and its subspecie by radioimmunoassay and analytical isoelectric focusing: abnormal plasma triglyceride-rich lipoprotein apolipoprotein C-III subspecie concentrations in hypertriglyceridemia. J Lipid Res. 1981 Jul; 22(5):800-10. Kashyap ML, Srivastava LS, Hynd BA, Gartside PS, Perisutti G. PMID: 7288286.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    128. Plasma lipids and lipoprotein lipase activating property in women on three different combinations of estrogens and progestins. Biochem Med. 1981 Jun; 25(3):283-7. Mendoza SG, Kashyap ML, Echeverria Y, Zerpa A. PMID: 7271764.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    129. Abnormal preponderance of sialylated apolipoprotein CIII in triglyceride rich lipoproteins in type V hyperlipoproteinemia. Metabolism. 1981 Feb; 30(2):111-8. Kashyap ML, Hynd BA, Robinson K, Gartside PS. PMID: 7464559.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    130. Catabolism of human very low density lipoproteins in vitro: a fluorescent phospholipid method for monitoring lipolysis. J Lipid Res. 1981 Feb; 22(2):382-6. Taskinen MR, Johnson JD, Kashyap ML, Shirai K, Glueck CJ, Jackson RL. PMID: 6894609.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    131. Post-heparin plasma lipoprotein and hepatic lipases. Relationships to high density lipoprotein cholesterol and to apolipoprotein CII in familial hyperalphalipoproteinemic and in normal subjects. Atherosclerosis. 1980 Oct; 37(2):247-56. Taskinen MR, Glueck CJ, Kashyap ML, Srivastava LS, Hynd BA, Perisutti G, Robinson K, Kinnunen PJ, Kuusi T. PMID: 7426098.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    132. A rapid and simple method for measurement of total protein in very low density lipoproteins by the Lowry assay. J Lipid Res. 1980 May; 21(4):491-5. Kashyap ML, Hynd BA, Robinson K. PMID: 7381338.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    133. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome. Atherosclerosis. 1980 Jan; 35(1):29-40. Kashyap ML, Srivastava LS, Hynd BA, Brady D, Perisutti G, Glueck CJ, Gartside PS. PMID: 7370086.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    134. The role of high density lipoprotein apolipoprotein CII in triglyceride metabolism. Lipids. 1978 Dec; 13(12):933-42. Kashyap ML, Srivastava LS, Hynd BA, Perisutti G, Brady DW, Gartside P, Glueck CJ. PMID: 220489.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    135. Octogenarian Kindred: hyper-alpha-lipoproteinemia. Prev Med. 1978 Mar; 7(1):1-14. Glueck CJ, Gartside PS, Miller L, Steiner PM, Todhunter T, Terrana M, Haaf J, Kashyap ML. PMID: 204917.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    136. Familial hypertriglyceridemia in children: dietary management. Pediatr Res. 1977 Sep; 11(9 Pt 1):953-7. Glueck CJ, Mellies MJ, Tsang RC, Kashyap ML, Steiner PM. PMID: 904981.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    137. Hyperalpha- and hypobeta-lipoproteinemia in octogenarian kindreds. Atherosclerosis. 1977 Aug; 27(4):387-406. Glueck CJ, Gartside PS, Steiner PM, Miller M, Todhunter T, Haaf J, Pucke M, Terrana M, Fallat RW, Kashyap ML. PMID: 196605.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    138. Radioimmunoassay of human apolipoprotein CII. A study in normal and hypertriglyceridemic subjects. J Clin Invest. 1977 Jul; 60(1):171-80. Kashyap ML, Srivastava LS, Chen CY, Perisutti CG, Campbell M, Lutmer RF, Glueck CJ. PMID: 194919; PMCID: PMC372355.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    139. High density lipoproteinuria in nephrotic syndrome. Metabolism. 1976 Oct; 25(10):1143-9. de Mendoza SG, Kashyap ML, Chen CY, Lutmer RF. PMID: 184367.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    140. Composition of HDL-2 and HDL-3 in familial hyperalphalipoproteinemia. Atherosclerosis. 1976 Oct; 25(1):131-6. Mendoza S, Lutmer RF, Glueck CJ, Chen CY, Steiner PM, Fallat RW, Kashyap ML. PMID: 186077.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    141. Carbohydrate and lipid metabolism during human labor: free fatty acids, glucose, insulin, and lactic acid metabolism during normal and oxytocin-induced labor for postmaturity. Metabolism. 1976 Aug; 25(8):865-75. Kashyap ML, Sivasamboo R, Sothy SP, Cheah JS, Gartside PS. PMID: 940472.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    142. Role of adipose tissue in free fatty acid metabolism in hemorrhagic hypotension and shock. Metabolism. 1975 Jul; 24(7):855-60. Kashyap ML, Tay JS, Sothy SP, Morrison JA. PMID: 1138160.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    143. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest. 1973 Jan; 52(1):32-8. Havel RJ, Kane JP, Kashyap ML. PMID: 4345202; PMCID: PMC302224.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    Moti's Networks
    Concepts (459)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California